Vericel CLO exercises options, sells 15K shares
Vericel Corp's Chief Legal Officer Sean C. Flynn exercised stock options and sold shares in a planned transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Vericel Corp's Chief Legal Officer Sean C. Flynn exercised stock options and sold shares in a planned transaction. On June 26, 2026, he exercised options to acquire 15,000 shares of common stock at $16.25 per share, then sold 15,000 shares in an open-market transaction at an average price of $45.64 per share. The sales were made under an automatic Rule 10b5-1 trading plan adopted on December 2, 2025. After these transactions, he directly held 1,647 shares of Vericel common stock.
Insider Trade Summary 10b5-1
Exercise and Sale: 15,000 shares ($441K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Flynn Sean C.
Role
Chief Legal Officer
Sold
15,000 shs ($685K)
Approx. gross sale proceeds
$685K
Approx. exercise cost
$244K
Approx. pre-tax spread
$441K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,000 | $16.25 | $244K |
| Sale | Common Stock | 15,000 | $45.64 | $685K |
Holdings After Transaction:
Stock Option (Right to Buy) — 55,000 contracts (Direct);
Common Stock — 1,647 shares (Direct)
Footnotes (3)
- F1. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- F2. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
- F3. These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Key Figures
Shares sold: 15,000 shares
Sale price: $45.64 per share
Options exercised: 15,000 shares
+5 more
8 metrics
Shares sold
15,000 shares
Open-market sale of common stock on June 26, 2026
Sale price
$45.64 per share
Average price for 15,000 shares sold
Options exercised
15,000 shares
Common stock acquired via option exercise on June 26, 2026
Option strike price
$16.25 per share
Exercise price for 15,000 options
Shares held after
1,647 shares
Direct Vericel common stock holdings after transactions
Options grant size
150,000 shares
Underlying shares for option grant described in footnote
10b5-1 plan adoption date
December 2, 2025
Date trading plan was adopted for automatic sales
Option expiration
November 4, 2029
Expiration date for the stock options exercised
Key Terms
Rule 10b5-1 trading plan, Employee Stock Purchase Plan, Rule 16b-3(d), Stock Option (Right to Buy), +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Purchase Plan financial
"These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(d) regulatory
"transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... representing the right to purchase 150,000 shares"
vesting financial
"with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Vericel (VCEL) executive Sean C. Flynn report in this Form 4?
Sean C. Flynn, Vericel’s Chief Legal Officer, reported exercising options for 15,000 shares at $16.25 and selling 15,000 common shares at $45.64 on June 26, 2026. These trades were part of a pre-arranged Rule 10b5-1 trading plan.
What stock options did Sean C. Flynn exercise in Vericel (VCEL)?
He exercised stock options covering 15,000 shares of Vericel common stock at a strike price of $16.25 per share. A footnote explains these options are part of a larger grant that became exercisable beginning November 4, 2020, with vesting over several years.
What is noted about Sean C. Flynn’s Vericel (VCEL) options grant and vesting?
A footnote says the options represent rights to purchase 150,000 shares, first exercisable on November 4, 2020. Twenty-five percent vested at that time, with the remaining 75% vesting in equal quarterly installments over three years, contingent on continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates